ArticleCancer immunology research2026

In Situ Vaccination, Low-Dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models.

Trishna Debnath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.